This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Lung cancer screening with low-dose chest computed tomography (CT) may detect more than just lung cancer. As research in the Canadian Medical Association Journal shows, these CTs can identify coronaryartery calcium, a strong risk factor for coronaryarterydisease (CAD), in patients without cardiac symptoms.
Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. Cleerly’s pioneering approach to advanced cardiovascular imaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronaryarterydisease.
Researchers have discovered that the smooth muscle cells that line the arteries of people with atherosclerosis can change into new cell types and develop traits similar to cancer that worsen the disease.
It has been shown that patients with cancer have a longer expected life duration, benefiting from advanced medical therapy. Meanwhile, the risk of suffering from cardiovascular disease (CVD) has been increasing with ageing. A growing number of studies have elucidated the association between cancer and CVD.
Cancer and cardiovascular disease represent the two leading causes of morbidity and mortality worldwide. However, this comes at a cost with more women developing diabetes, hypertension and coronaryarterydisease as they age. Women continue to enjoy a greater life expectancy than men.
Coronaryarterydisease is caused by the retention of a cholesterol particle in the artery wall. Insulin resistance and diabetes may not ‘ cause ’ coronaryarterydisease, but they are huge accelerants. If delaying the onset of major chronic disease is your goal. Timing Matters.
Inflammation is a key driver of heart disease, specifically coronaryarterydisease. I have covered this topic previously here , but it is clear that inflammation plays a major role in the initiation and progression of coronaryarterydisease, and the inflammatory biomarker hsCRP is tightly connected to this process.
If you do not have coronaryarterydisease the probability of you dying from it then is very low. The factors that we have discussed so far are all important risk factors for developing coronaryarterydisease. You decide. You measure.
Chest radiotherapy (XRT) plays a crucial role in the treatment of a multitude of cancers including breast, lung, esophageal, and lymphoma. Although XRT enhances cancer survival rates, it may also expose healthy bystander tissues to radiation, potentially leading to severe complications.
While exercise testing typically is focused on diagnosing coronaryarterydisease, a recent study finds that exercise test abnormalities, such as low functional aerobic capacity, predicted non-cardiovascular causes of death such as cancer in addition to cardiovascular-related deaths.
Understanding where you sit on this continuum is a key part of defining your future risk of heart disease but also dementia, and many cancers. Even having one of the metabolic syndrome factors increases the risk of dying from heart disease by 73% 4. Metabolic syndrome can be assessed easily and cheaply in any healthcare setting.
is the upgraded version of Nanox.AI’s cardiac solution, HealthCCSng, which has already shown tangible results in several healthcare systems, identifying patients at high risk of coronaryarterydisease while driving significant revenue to cardiology departments. HealthCCSng V2.0
I think especially with the recent changes in guidelines and the recommendation to use CT for screening of coronaryarterydisease, we expect to see this trend really impact the way CT is used in the future.” Lung cancer is the leading cause of cancer-related death for US veterans.
Cardiovascular disease is the leading cause of death worldwide. It kills almost twice as many people globally when compared to all cancers combined. Over 80% of early heart disease is preventable. However, most adults will start to develop advanced plaque in their coronaryarteries early in life. The answer is yes.
Diamond and Forrester accomplished this by first establishing the prevalence of coronaryarterydisease based on how clinically likely patients with chest pain symptoms were found to have coronarydisease based on a coronary angiogram. Thanks for reading Dr. Anish Koka's Newsletter!
24% increased risk of coronaryarterydisease. Watching the World Cup is associated with a two-fold increased risk of dying from heart disease. Receiving a cancer diagnosis is associated with a more than five-fold increased risk of a cardiovascular event 5. These findings have been replicated multiple times.
All comorbidities, except for coronaryarterydisease (CAD), were more frequent in HF with preserved EF (HFpEF). CAD and valvular heart disease were associated with a higher risk of all-cause and CV mortality, but not non-CV mortality, whereas cancer and muscolo-skeletal disease increased the risk of non-CV mortality.
The most common etiologies of 90‐day readmission among diabetics were cardiovascular (28.98%), neurological (12.92%), and infectious (7.72%).ConclusionDiabetics ConclusionDiabetics had higher 90‐day readmission following TIA than non‐diabetics.
The complications of the procedure and patient’s outcomes were discussed.MethodsWe identified two patients who were admitted to our medical center between January 2022 to December 2022 for subclavian‐carotid artery bypass procedure. Clinical data were reviewed retrospectively.ResultsCase 1.
A 56 year old male with a history of diabetes, dyslipidemia, hypertension, and coronaryarterydisease presented to the emergency department with sudden onset weakness, fatigue, lethargy, and confusion. This is another case sent by the undergraduate (who is applying to med school) who works as an EKG tech.
BackgroundThere is limited knowledge regarding the association between heart rate (HR) during different exercise phases and coronaryarterydisease (CAD). This study aimed to evaluate the relationship between four exercise-related HR metrics detected by cardiopulmonary exercise testing (CPET) and CAD.
Getty Images milla1cf Mon, 04/29/2024 - 13:06 April 29, 2024 — Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024 , a scientific congress of the European Society of Cardiology ( ESC ).1 2Knuuti J, Wijns W, Saraste A, et al.
Healy, MD, FACC, published an editorial in the New England Journal of Medicine highlighting the findings of two studies in that issue demonstrating clear evidence of sex bias in the management of coronaryarterydisease.2 These have ranged from heart attacks, cardio-obstetrics, breast cancer, prevention and arrhythmias.8-13
Background The Naples prognostic score (NPS) is an effective inflammatory and nutritional scoring system widely applied as a prognostic factor in various cancers. However, the prognostic significance of NPS is unknown in ST-segment elevation myocardial infarction (STEMI).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content